
- Volume 0 0
More African Americans Have Low-LDL Gene Mutations
A study, reported on-line in NatureGenetics (January 16, 2005), found that 2genetic mutations that are common inindividuals of African descent are linkedwith a 50% reduction in low-densitylipoprotein (LDL) cholesterol. Earlier studiesinvolving mice showed that othermutations in the gene PCSK9 cause highcholesterol levels with raised LDL levels.To determine if there might be PCSK9variations that have the opposite effect,researchers examined the deoxyribonucleicacid sequence of PCSK9 in 128adults (half were African American) withlow LDL levels.
The results of the study indicated thatmutations in PCSK9 were shown in 2% ofAfrican Americans, but in <0.1% of EuropeanAmericans. The findings alsoshowed that carriers of the variant geneshad significantly lower LDL and total cholesterollevels, compared with noncarriers.Based on the study's results, the researchersnoted that the genetic mutationsidentified are "the most common sequencevariants yet described to have large effectson plasma cholesterol levels."
Articles in this issue
over 21 years ago
Heart Patients Get More Appropriate Rx Treatment from Cardiologistsover 21 years ago
Surgeon General Report Blasts Rx Drug Importing Practicesover 21 years ago
Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDAover 21 years ago
Expo Focuses on Caregiver Needsover 21 years ago
Early-Month Rx Fatalities Linked to Overworked Pharmacistsover 21 years ago
Feds Report Rx Expenditures Rose More Slowly in 2004over 21 years ago
Rx.com Offers Alternative to PBM Mail Orderover 21 years ago
Americans Rate US Health Care as Poorover 21 years ago
Pharmacy Security Combo Pack Now Availableover 21 years ago
IOM Advocates Tougher Supplement Standards





































































































































